WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007096185) PRIMATE MODEL FOR ORTHOPOX VIRUS INFECTIONS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2007/096185    International Application No.:    PCT/EP2007/001593
Publication Date: 30.08.2007 International Filing Date: 23.02.2007
IPC:
C12N 7/00 (2006.01), C07K 14/065 (2006.01), A61K 35/76 (2006.01), A61K 39/275 (2006.01)
Applicants: DEUTSCHES PRIMATENZENTRUM GMBH [DE/DE]; Kellnerweg 4, 37077 Goettingen (DE) (For All Designated States Except US).
KAUP, Franz-Josef [DE/DE]; (DE) (For US Only).
MAETZ-RENSING, Kerstin [DE/DE]; (DE) (For US Only).
STAHL-HENNIG, Christiane [DE/DE]; (DE) (For US Only).
PAULI, Georg [DE/DE]; (DE) (For US Only).
ELLERBROK, Heinz [DE/DE]; (DE) (For US Only)
Inventors: KAUP, Franz-Josef; (DE).
MAETZ-RENSING, Kerstin; (DE).
STAHL-HENNIG, Christiane; (DE).
PAULI, Georg; (DE).
ELLERBROK, Heinz; (DE)
Agent: SANDMANN, Wolfgang; Reinhard, Skuhra, Weise & Partner GbR, Friedrichstr. 31, 80801 Munich (DE)
Priority Data:
06003847.8 24.02.2006 EP
Title (EN) PRIMATE MODEL FOR ORTHOPOX VIRUS INFECTIONS
(FR) MODÈLE DE PRIMATES POUR INFECTIONS PAR UN VIRUS ORTHOPOX
Abstract: front page image
(EN)The present invention is directed to an animal model for predicting the course of orthopox virus infections or for evaluating the efficacy of anti-viral therapeutics or anti-orthopox virus vaccines. The present invention is further directed to a method of evaluating the efficacy of an anti-viral therapeutic or an anti-orthopox virus vaccine and to a specific Callithrixpox virus strain for use in this method. Furthermore, the present invention pertains to a pharmaceutical composition containing such an anti-viral therapeutic or an anti-orthopox virus vaccine.
(FR)La présente invention concerne un modèle animal permettant la prédiction de l'évolution d'infections par un virus orthopox ou l'évaluation de l'efficacité de produits thérapeutiques antiviraux ou de vaccins anti-virus orthopox. La présente invention concerne en outre une méthode d'évaluation de l'efficacité d'un produit thérapeutique antiviral ou d'un vaccin anti-virus orthopox, ainsi qu'une souche virale spécifique de type Callithrixpox employée dans cette méthode. De plus, la présente invention concerne une composition pharmaceutique contenant un tel produit thérapeutique antiviral ou vaccin anti-virus orthopox.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)